Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-4.09	63.52	66.24
Graham Fair Price	-89.49	2.41	22.92
PEG	24351.56	13.58	0.06
Price/Book	17.37	1.25	1.07
Price/Cash Flow	-93.30	-84.60	1262.60
Prices/Earnings	10700.38	1377.37	-12.75
Price/Sales	17.90	3.20	2.71
Price/FCF	-93.30	-84.60	1262.60
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	9.12	0.22	0.20
Operating Margin	17.19	0.03	0.03
ROA	-98.90	< 0.005	< 0.005
ROE	-0.02	< 0.005	-98.91
ROIC	< 0.005	< 0.005	46.77
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	< 0.005	< 0.005	-18.73
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.62	0.18	-71.11
EPS QOQ	-2.30	1.01	-55.83
FCF QOQ	-0.97	-18.72	-1827.75
Revenue QOQ	< 0.005	< 0.005	203.26
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	< 0.005	100.00
Days Sales Outstanding (DSO)	444.12	111.97	-74.79
Inventory Turnover	0.00	9829.02	100.00
Debt/Capitalization	0.45	0.45	-0.33
Quick Ratio	1.04	1.09	4.90
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	33.43	33.70	0.79
Cash	1.07	0.79	-26.26
Capex	-0.27	-0.17	34.93
Free Cash Flow	0.03	-0.50	1665.63
Revenue	13.13	13.18	0.34
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	1.15	1.20	4.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	28.44	24.88	-12.51
Naive Interpretation	Member

06 - Financial Health · Bad

Rating